Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Total 13F shares
-
20,412,545
-
Share change
-
+165,440
-
Total reported value
-
$128,387,657
-
Put/Call ratio
-
53%
-
Price per share
-
$6.27
-
Number of holders
-
82
-
Value change
-
-$793,343
-
Number of buys
-
35
-
Number of sells
-
43
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q3 2021
As of 30 Sep 2021 Niagen Bioscience, Inc. - Common Stock (NAGE) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,412,545 shares of stock of the company.
Largest 10 holders included Yong Rong (HK) Asset Management Ltd, BlackRock Inc., VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, ICONIQ Capital, LLC, BARCLAYS PLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, and Uniplan Investment Counsel, Inc..
This table shows 83 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.